A Study on the Control of Chronic Obstructive Pulmonary Disease (COPD) in Patients Taking the Combination of Tiotropium and Olodaterol Using the Respimat® Inhaler
Clinical trial NCT03663569 · COMPLETED
Trial details
- NCT number
- NCT03663569
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2018-08-15
- Primary completion
- 2019-10-04
- Enrollment
- 4819
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.